Scientists from A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) have identified why certain lung cancer cells ...

When the team knocked out the P2Y2 receptor in drug-resistant cancer cells, it led to an almost complete loss of the mutant EGFR protein.

In a media release on Jan. 22, it was revealed that a group of scientists from the Agency for Science, Technology and ...

In this retrospective study, researchers explored whether reducing osimertinib dose in EGFR-mutated metastatic NSCLC patients who experienced adverse events would worsen survival.

AstraZeneca Canada is pleased to announce that Tagrisso® (osimertinib) and Calquence® (acalabrutinib tablets) are now ...

A life-saving fundraiser is underway to support cancer treatment for a much-loved animal welfare advocate. Dorset-based solar company Save Energy UK is supporting the £80,000 appeal for Nicky, founder ...

Explore groundbreaking research on pancreatic cancer treatment that shows promise in inducing complete tumour regression.

Circulating tumour DNA (ctDNA) is transforming how we diagnose and treat complex cancers, particularly when clinical pathways ...

DelveInsight's RET Fusion Targeted Therapies Market Size, Target Population, Competitive Landscape & Market Forecast report includes a comprehensive understanding of current treatment practices, ...

Spanish researchers report a major pancreatic cancer breakthrough in mice, with a triple-drug therapy eliminating tumours by targeting the KRAS pathway, raising hopes for future human trials.

A three-drug therapy has eliminated pancreatic tumors in mice, according to a new study by Spanish researchers. ALSO READ: ...

Pancreatic cancer remains one of the deadliest cancers known, but two independent experimental therapies have now ...